Vektor Medical — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Vektor Medical is a private, commercial-stage company offering a novel AI-powered arrhythmia mapping solution. Its core product, vMap, translates standard ECG data into a 3D map of the heart to identify arrhythmia sources for conditions like atrial fibrillation and ventricular tachycardia, aiming to improve procedural planning and success rates. The company has generated clinical evidence demonstrating reductions in procedure time and improvements in arrhythmia-free survival. Vektor is positioned to address a significant global cardiovascular burden by integrating into existing electrophysiology lab workflows.

Cardiovascular

Technology Platform

vMap: An AI and biophysics-based computational platform that analyzes standard 12-lead ECGs to non-invasively create 3D maps identifying the source location of cardiac arrhythmias.

Opportunities

The massive and growing global burden of arrhythmias, particularly atrial fibrillation, creates a large addressable market.

vMap's non-invasive, software-based nature allows for easy integration into existing workflows and offers a cost-effective solution that could expand access to advanced mapping in community hospital settings, beyond major academic centers.

Risk Factors

Key risks include the challenge of changing physician behavior and integrating into established EP lab workflows dominated by large competitors.

Securing adequate reimbursement from payers is critical for adoption, and the company must continue to generate robust clinical evidence to support its value proposition against invasive gold-standard mapping systems.

Competitive Landscape

Vektor competes with large, established medical device companies (e.g., Abbott, Boston Scientific, Medtronic) that offer invasive electroanatomic mapping systems integrated with their ablation catheters. It also faces competition from other non-invasive mapping technologies and academic computational models. vMap's differentiation is its focus on pre-procedural planning from a standard ECG, aiming to complement rather than fully replace existing intra-procedural tools.

More companies in AI / Machine Learning →More companies in United States →